MA181021
Hepatitis B Virus X Monoclonal Antibody (3F6-G10), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MA181021-Each-of-1 | In Stock | ₹ 50,774.50 |
MA181021 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 50,774.50
GST (18%): ₹ 9,139.41
Total Price: ₹ 59,913.91
Antigen
Hepatitis B Virus X
Classification
Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 0.1% BSA and 0.09% sodium azide
Host Species
Mouse
Purification Method
Protein G
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG2a
Applications
ELISA, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)
Clone
3F6-G10
Conjugate
Unconjugated
Gene Alias
HBV; HBVgp3; HepB; HepB X
Immunogen
HB-Xag-Protein A Fusion protein.
Quantity
250 μg
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- A suggested positive control for immunohistochemical applications is liver carcinoma/hepatitis B infected liver
- This product does not require protein digestion pre-treatment of paraffin embedded sections
- This product does not require antigen retrieval using heat treatment prior to staining of paraffin embedded sections
- Mouse anti Hepatitis B-X antibody, clone 3F6-G10 recognizes the HB-X antigen of hepatitis virus
- The hepatitis B virus is an important cause of acute and chronic liver disease
- It is also the most common form of parenterally transmitted viral hepatitis
- The Hepatitis B X antigen is a 154 amino acid ∽17 kDa multifunctional protein involved in the development of liver chirrosis and hepatocellular carcinoma
- The virus is estimated to affect some 350 million people worldwide
- Immunization against hepatitis B is an important component of preventative medicine and is offered to all children in approximately 30 countries
- Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and infection with HBV is usually more serious than infection with hepatitis A virus
- In some individuals the infection is not cleared and followed by persistent intracellular viral carriage that can lead to the development of hepatocelular carcinomas
- There are currently 400 million HBV carriers worldwide making HBV one of the most common human pathogens.